Lestaurtinib

lestaurtinib · Cephalon

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lestaurtinib, covering 2016-05-18 to 2016-07-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML) [Phase 2]